735 related articles for article (PubMed ID: 17619064)
21. Stability of pharmaceutical salts in solid oral dosage forms.
Nie H; Byrn SR; Zhou QT
Drug Dev Ind Pharm; 2017 Aug; 43(8):1215-1228. PubMed ID: 28276282
[TBL] [Abstract][Full Text] [Related]
22. Methodology for phase selection of a weak basic drug candidate, utilizing kinetic solubility profiles in bio-relevant media.
Furukawa S; Zhao C; Ohki Y
Eur J Pharm Biopharm; 2010 Feb; 74(2):298-303. PubMed ID: 19815062
[TBL] [Abstract][Full Text] [Related]
23. Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturatable dosage forms for improving bioavailability of poorly absorbed drugs.
Kawakami K
Adv Drug Deliv Rev; 2012 May; 64(6):480-95. PubMed ID: 22265844
[TBL] [Abstract][Full Text] [Related]
24. An evaluation of salt screening methodologies.
Fernández Casares A; Nap WM; Ten Figás G; Huizenga P; Groot R; Hoffmann M
J Pharm Pharmacol; 2015 Jun; 67(6):812-22. PubMed ID: 25683791
[TBL] [Abstract][Full Text] [Related]
25. A case study where pharmaceutical salts were used to address the issue of low in vivo exposure.
Sigfridsson K; Ulvinge ML; Svensson L; Granath AK
Drug Dev Ind Pharm; 2019 Feb; 45(2):202-211. PubMed ID: 30256689
[TBL] [Abstract][Full Text] [Related]
26. Comparative physical, mechanical and crystallographic properties of a series of gemfibrozil salts.
David SE; Ramirez M; Timmins P; Conway BR
J Pharm Pharmacol; 2010 Nov; 62(11):1519-25. PubMed ID: 21039537
[TBL] [Abstract][Full Text] [Related]
27. Evaluating drug delivery with salt formation: Drug disproportionation studied in situ by ATR-FTIR imaging and Raman mapping.
Ewing AV; Wray PS; Clarke GS; Kazarian SG
J Pharm Biomed Anal; 2015; 111():248-56. PubMed ID: 25910459
[TBL] [Abstract][Full Text] [Related]
28. Physical stability of salts of weak bases in the solid-state.
Stephenson GA; Aburub A; Woods TA
J Pharm Sci; 2011 May; 100(5):1607-17. PubMed ID: 21374599
[TBL] [Abstract][Full Text] [Related]
29. The preparation and evaluation of salt forms of linogliride with reduced solubilities as candidates for extended release.
Chrzanowski FA; Ahmad K
Drug Dev Ind Pharm; 2017 Mar; 43(3):421-431. PubMed ID: 27808569
[TBL] [Abstract][Full Text] [Related]
30. Comparison of a rational vs. high throughput approach for rapid salt screening and selection.
Collman BM; Miller JM; Seadeek C; Stambek JA; Blackburn AC
Drug Dev Ind Pharm; 2013 Jan; 39(1):29-38. PubMed ID: 22380522
[TBL] [Abstract][Full Text] [Related]
31. New ideas about the solubility of drugs.
Box K; Comer JE; Gravestock T; Stuart M
Chem Biodivers; 2009 Nov; 6(11):1767-88. PubMed ID: 19937815
[TBL] [Abstract][Full Text] [Related]
32. Biphasic dissolution method for quality control and assurance of drugs containing active substances in the form of weak acid salts.
Franc A; Muselłk J; Goněc R; Vetchý D
Acta Pharm; 2016 Mar; 66(1):139-45. PubMed ID: 26959550
[TBL] [Abstract][Full Text] [Related]
33. Silica precipitation in acidic solutions: mechanism, pH effect, and salt effect.
Gorrepati EA; Wongthahan P; Raha S; Fogler HS
Langmuir; 2010 Jul; 26(13):10467-74. PubMed ID: 20536253
[TBL] [Abstract][Full Text] [Related]
34. Estimating the maximal solubility advantage of drug salts.
Skrdla PJ
Int J Pharm; 2021 Feb; 595():120228. PubMed ID: 33484924
[TBL] [Abstract][Full Text] [Related]
35. Modifying the diffusion layer of soluble salts of poorly soluble basic drugs to improve dissolution performance.
Hawley M; Morozowich W
Mol Pharm; 2010 Oct; 7(5):1441-9. PubMed ID: 20731341
[TBL] [Abstract][Full Text] [Related]
36. Preformulation study of a poorly water-soluble drug, alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol: selection of the base for dosage form design.
Serajuddin AT; Sheen PC; Mufson D; Bernstein DF; Augustine MA
J Pharm Sci; 1986 May; 75(5):492-6. PubMed ID: 3735089
[TBL] [Abstract][Full Text] [Related]
37. Standardization of the physicochemical parameters to assess in vitro the beta-hematin inhibitory activity of antimalarial drugs.
Parapini S; Basilico N; Pasini E; Egan TJ; Olliaro P; Taramelli D; Monti D
Exp Parasitol; 2000 Dec; 96(4):249-56. PubMed ID: 11162378
[TBL] [Abstract][Full Text] [Related]
38. Effect of chloride ion on dissolution of different salt forms of haloperidol, a model basic drug.
Li S; Doyle P; Metz S; Royce AE; Serajuddin AT
J Pharm Sci; 2005 Oct; 94(10):2224-31. PubMed ID: 16136556
[TBL] [Abstract][Full Text] [Related]
39. Computational oral absorption simulation of free base drugs.
Sugano K
Int J Pharm; 2010 Oct; 398(1-2):73-82. PubMed ID: 20655999
[TBL] [Abstract][Full Text] [Related]
40. Propranolol forms affect properties of Carbopol-containing extruded-spheronized beads.
Paker-Leggs S; Neau SH
Int J Pharm; 2008 Sep; 361(1-2):169-76. PubMed ID: 18601988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
